Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

NCT03616782 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Ixazomib

Sponsor

Ho Sup Lee

Collaborators

[object Object]